Display options
Cite
Lebedeva AV, Shchukin IA, Soldatov MA, et al. Asteniia, émotsional'nye rasstroĭstva i kachestvo zhizni u patsientov s rasseiannym sklerozom. [Asthenia, emotional disorders and quality of life of patients with multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(10):99-104
Lebedeva, A. V., Shchukin, I. A., Soldatov, M. A., Boĭko, O. V., Petrov, S. V., Khozova, A. A., Ismailov, A. M., Shikhkerimov, R. K., & Boĭko, A. N. (2014). Asteniia, émotsional'nye rasstroĭstva i kachestvo zhizni u patsientov s rasseiannym sklerozom. [Asthenia, emotional disorders and quality of life of patients with multiple sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 114(10), 99-104.
Lebedeva, A V, et al. "Asteniia, émotsional'nye rasstroĭstva i kachestvo zhizni u patsientov s rasseiannym sklerozom." [Asthenia, emotional disorders and quality of life of patients with multiple sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova vol. 114,10 (2014): 99-104.
Lebedeva AV, Shchukin IA, Soldatov MA, Boĭko OV, Petrov SV, Khozova AA, Ismailov AM, Shikhkerimov RK, Boĭko AN. Asteniia, émotsional'nye rasstroĭstva i kachestvo zhizni u patsientov s rasseiannym sklerozom. [Asthenia, emotional disorders and quality of life of patients with multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(10):99-104. Russian. PMID: 25591540.
Copy Download .nbib Format: NLM
Share it on

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(10):99-104.

[Asthenia, emotional disorders and quality of life of patients with multiple sclerosis].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

[Article in Russian]
A V Lebedeva, I A Shchukin, M A Soldatov, O V Boĭko, S V Petrov, A A Khozova, A M Ismailov, R K Shikhkerimov, A N Boĭko

Affiliations

  1. GBOU VPO "Rossi?ski? natsional'ny? issledovatel'ski? meditsinski? universitet im. N.I. Pirogova", Moskva.
  2. GBOU VPO "Rossi?ski? natsional'ny? issledovatel'ski? meditsinski? universitet im. N.I. Pirogova", Moskva; GBUZ "Gorodskaia klinicheskaia bol'nitsa #1 im. N.I. Pirogova", Moskva.
  3. GBUZ "Gorodskaia klinicheskaia bol'nitsa #1 im. N.I. Pirogova", Moskva.
  4. GBOU VPO "Rossi?ski? natsional'ny? issledovatel'ski? meditsinski? universitet im. N.I. Pirogova", Moskva; Moskovski? gorodsko? tsentr rasseiannogo skleroza, filial #1 GBUZ "Gorodskaia klinicheskaia bol'nitsa #24 DZM", Moskva.

PMID: 25591540

Abstract

Objective. The evaluation of the dynamics of asthenia, chronic fatigue syndrome, emotional disorders and quality of life of patients with multiple sclerosis (MS) and to explore the possibility of using idebenon (noben) in treatment of these impairments. Material and methods. We studied 35 patients, 18 men and 17 women, with MS (mean age 36.4±8.86 years, mean disease duration 10.33±6.07 years); 83% of patients had remitting type and others - secondary progressive type. Along with neurological examination, we used the Modified Fatigue Impact Scale (MFIS 21), the Hospital Anxiety and Depression Scale and a quality of life questionnaire (EQ5D). Patients had marked asthenia and chronic fatigue at baseline. The old age of the patients and duration of MS and its severity according to EDSS predicted the higher levels of asthenia, chronic fatigue and anxiety with depression and lower quality of life on EQ5D. All patients received noben in dosage 90 mg daily (30 mg 3 times a day) during 6 months. Results and conclusion. Idebenon (noben) reduced the severity of chronic fatigue syndrome, asthenia and depression in MS patients. The dose used in the study may be regarded as the optimal dose that provides best efficacy with minimal side-effects.

Publication Types